股票/基金 实时行情 股吧

简称:博济医药 代码:300404


会计年度:2021-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
服务业324,202,622.53184,083,725.16140,118,897.3743.22
合计324,202,622.53184,083,725.16140,118,897.3743.22

会计年度:2020-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
服务业260,468,434.47146,655,841.57113,812,592.9043.70
合计260,468,434.47146,655,841.57113,812,592.9043.70

会计年度:2019-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
服务业224,055,854.83128,777,359.8295,278,495.0142.52
合计224,064,704.39128,777,359.8295,287,344.5742.53
销售8,849.56------

会计年度:2019-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
临床前研究服务15,413,782.748,289,946.647,123,836.1046.22
临床研究服务69,651,971.0941,774,044.9427,877,926.1540.02
其他咨询服务7,873,061.512,493,470.895,379,590.6268.33

会计年度:2018-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
服务业172,042,840.4993,588,387.2778,454,453.2245.60
合计172,042,840.4993,588,387.2778,454,453.2245.60

    1/3 转到